SCHEMBL4437200

SCHEMBL4437200

CC(C)(C)[Si](C)(C)O[C@@H]1CCNC[C@H]1N(C(=O)O)c1ccncc1NC(=O)c1ccc(F)c(Br)n1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 19/20 0.38
PIM3 Q86V86 19/20 0.38
PIM2 Q9P1W9 19/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444690 0.88 PIM3 (0.37) PIM1PIM3PIM2
SCHEMBL3411679 0.87 PIM1 (0.40) PIM1PIM3PIM2
SCHEMBL3411675 0.87 PIM1 (0.40) PIM1PIM3PIM2
SCHEMBL12495335 0.87 PIM1 (0.36) PIM1PIM3PIM2
SCHEMBL4444769 0.83 PIM1 (0.35) PIM1PIM3PIM2
SCHEMBL4438383 0.83 PIM2 (0.34) PIM1PIM3PIM2
SCHEMBL4437099 0.83 PIM2 (0.34) PIM1PIM3PIM2
SCHEMBL4439852 0.82 PIM3 (0.37) PIM1PIM3PIM2
SCHEMBL4435474 0.80 PIM2 (0.49) PIM1PIM3PIM2
SCHEMBL1710369 0.78 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed